Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Rindopepimut |
Synonyms | |
Therapy Description |
Rindopepimut (CDX-110) is a peptide vaccine that targets EGFRvIII, which may stimulate immune response against EGFRvIII-expressing cells (PMID: 32034072). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Rindopepimut | CDX-110|PF-04948568 | Rindopepimut (CDX-110) is a peptide vaccine that targets EGFRvIII, which may stimulate immune response against EGFRvIII-expressing cells (PMID: 32034072). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|